Concomitant chemoradiation treatment in the management of patients with extrahepatic biliary tract recurrence of gastric carcinoma

Cancer

Volumn 89, Issue 1, 2000, Pages 29-34

  Lo, Su Shun ^a,b   Wu, Chew Wun ^a   Chi, Kwan Hwa ^a   Tseng, Hsiuo Shan ^a   Shen, King Han ^a   Hsieh, Mao Chih ^a   Lui, Wing Yiu ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Chemoradiation; Malignant biliary obstruction; Recurrent gastric carcinoma

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; EXTRAHEPATIC BILE DUCT OBSTRUCTION; FEMALE; HUMAN; MALE; METASTASIS; PATIENT SATISFACTION; PERCUTANEOUS TRANSHEPATIC DRAINAGE; PRIORITY JOURNAL; STOMACH CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; BRACHYTHERAPY; CHOLESTASIS, EXTRAHEPATIC; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; PALLIATIVE CARE; RECURRENCE; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 0034234665     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000701)89:1<29::AID-CNCR5>3.0.CO;2-I     Document Type: Article

References (28)

1. Papachristou D, Fortner JG. Biliary obstruction after gastrectomy for carcinoma of the stomach. Surg Gynecol Obstet 1978;147:401-4.
2. Wu CC, Hsieh MC, Lo SS, Lui WY, P'eng FK. Results of curative gastrectomy for carcinoma of the distal third of the stomach. J Am Coll Surg 1996;183:201-7.
3. Vokes E and Weichselbaum R. Concomitant chemoradiotherapy. Rationale and clinical experience in patients with solid tumors. J Clin Oncol 1990;8:911-34.
4. Stell GG. The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiother Oncol 1988; 11:31-53.
5. Schahel FM, Trader ML, Laster WR Jr., Corbett TH, Griswold DP Jr. Cis-dichlorodiammine-platinum (II) combination chemotherapy and cross resistance studies with tumor mice. Cancer Treat Rep 1979;63:1459-73.
6. Kim NK, Park YS, Heo DS, Suh C, Kim SY, Park KC, et al. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer. Cancer 1993;71:3813-8.
7. Meyer JE, Messer RJ, Patel VC. Diagnosis and treatment of obstructive jaundice secondary to liver metastases. Cancer 1978;41:773-5.
8. Conroy GM, Shahbasian AA, Edwards KC, Moran EM, Swingle KF, Lewis GJ, et al. A new method for treating carcinomatous biliary obstruction with intracatheter radium. Cancer 1982;49:1321-7.
9. Johnson DW, Safai C, Goffinet DR. Malignant obstructive jaundice. Treatment with external beam and intracavitary radiotherapy. Int J Radiat Biol Phys 1985;11:411-6.
10. Molt P, Hopfan S, Watson RC, Botet JE, Brennan MF. Intraluminal radiation therapy in the management of malignant biliary obstruction. Cancer 1986;57:536-44.
11. Kim GE, Shin HS, Seong JS, Loh JJK, Suh CO, Lee JT, et al. The role of radiation treatment in management of extrahepatic biliary tract metastasis from gastric cancer. Int J Radiat Oncol Biol Phys 1994;28:711-7.
12. Kadakia SC, Starnes E. Comparison of 10 French gauge stent with 11.5 French gauge stent in patients with biliary tract diseases. Gastrointest Endosc 1992;38:454-9.
13. Speer AG, Cotton PB, MacRae KD. Endoscopic management of malignant biliary obstruction: stent of 10 French gauge are preferable to stents of 8 French gauge. Gastrointest Endosc 1988;34:412-7.
14. Walta DC, Fausel CS, Bolek B. Endoscopic biliary stents and obstructive jaundice. Am J Surg 1987;153:444-7.
15. Huibregtse K, Katon RM, Coene PP, Tytgat GNJ. Endoscopic palliative treatment in pancreatic cancer. Gastrointest Endosc 1986;32:334-8.
16. Tytgat GNJ, Bartelsman JFWM, Den Hautog Jager FCA, Huibregtse K, Mathus-Vliegen EMH. Upper intestinal and biliary tract endoprothesis. Dig Dis Sci 1986;31:575-6.
17. Speer AG, Cotton PB, Russell RCG, Mason RR, Hatfield ARW, Leung JWC, et al. Randomized trial of endoscopic v percutaneous stent insertion in malignant obstructive jaundice. Lancet 1987;2:57-62.
18. Anderson JR, Sorensen SM, Kruse A, Rokkjaer M, Matzen P. Randomized trial of endoscopic endoprothesis versus operative bypass in malignant obstructive jaundice. Gut 1989;30: 1132-5.
19. Polydorou AA, Cairns SR, Dowsett JF, Hatfield ARW, Salmon PR, Cotton PB, et al. Palliation of proximal malignant biliary obstruction by endoscopic endoprothesis insertion. Gut 1991;32:685-9.
20. Adam A. Metallic biliary endoprostheses. Cardiovasc Intervent Radiol 1994;17:127-32.
21. Stoker J, Lameris JS. Complications of percutaneously inserted biliary Wallstents. JVIR 1993;4:767-72.
22. Hreshchyshyn MM. Hydroxyurea with irradiation for cervical carcinoma: a preliminary report. Cancer Chemother Rep 1968;52:601-22.
23. Piver MS. Invasive cervical cancer in the 1990s. Semin Surg Oncol 1990;6:359-63.
24. Goolsby CD, Daly JW, Skinner OD. Combination of 5-fluorouracil and radiation as primary therapy of carcinoma of the cervix. Obstet Gynecol 1968;32:674-6.
25. Thomas G, Dembo A, Beale F, Bean H, Bush R, Herman J, et al. Concurrent radiation, mitomycin-C, and 5-fluorouracil in poor prognosis carcinoma of the cervix: preliminary results of a phase I-II study. Int J Radiat Oncol Biol Phys 1984;10:1785-90.
26. Potish RA, Twiggs LB, Adcock LL, Savage JE, Prem KA. Effect of cis-platinum on tolerance to radiation therapy in advanced cervical cancer. Am J Clin Oncol 1986;9:387-91.
27. Hill BT. Interaction between antitumor agents and radiation and the expression of resistance. Cancer Treat Rev 1991;149-90.
28. Chi KH, Chao Y, Chan WK, Lo SS, Chen SY, Yen SH,et al. Weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin: an effective chemotherapy in advanced gastric cancer. Br J Cancer 1998;77:1984-8.